ID   S4A7_HUMAN              Reviewed;        1214 AA.
AC   Q9Y6M7; A6NIA8; B2CI53; B5M449; B5M451; B5M452; B5M453; B6DY52;
AC   B6DY53; C9JST9; D3K174; D3K175; O60350; Q6AHZ9; Q9HC88; Q9UIB9;
DT   07-FEB-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 2.
DT   10-MAY-2017, entry version 141.
DE   RecName: Full=Sodium bicarbonate cotransporter 3;
DE   AltName: Full=Electroneutral Na/HCO(3) cotransporter;
DE   AltName: Full=Sodium bicarbonate cotransporter 2;
DE   AltName: Full=Sodium bicarbonate cotransporter 2b;
DE            Short=Bicarbonate transporter;
DE   AltName: Full=Solute carrier family 4 member 7;
GN   Name=SLC4A7; Synonyms=BT, NBC2, NBC2B, NBC3, NBCn1, SBC2, SLC4A6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND TISSUE SPECIFICITY.
RC   TISSUE=Retina;
RX   PubMed=9610397; DOI=10.1006/bbrc.1998.8658;
RA   Ishibashi K., Sasaki S., Marumo F.;
RT   "Molecular cloning of a new sodium bicarbonate cotransporter cDNA from
RT   human retina.";
RL   Biochem. Biophys. Res. Commun. 246:535-538(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, REGULATION, AND VARIANT LYS-326.
RC   TISSUE=Kidney, and Skeletal muscle;
RX   PubMed=10347222; DOI=10.1074/jbc.274.23.16569;
RA   Pushkin A., Abuladze N., Lee I., Newman D., Hwang J., Kurtz I.;
RT   "Cloning, tissue distribution, genomic organization, and functional
RT   characterization of NBC3, a new member of the sodium bicarbonate
RT   cotransporter family.";
RL   J. Biol. Chem. 274:16569-16575(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RC   TISSUE=Neuroepithelium;
RA   Romero M.F.;
RT   "Cloning of a HCO3 transporter, NT2-NBC, from human brain, similar to
RT   both the Anion exchangers (AEs) and the Na/Bicarbonate Cotransporters
RT   (NBCs).";
RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 6; 7; 8; 9; 10; 11 AND 12),
RP   ALTERNATIVE SPLICING, AND VARIANT LYS-326.
RC   TISSUE=Brain, Heart, Liver, and Skeletal muscle;
RA   Liu Y., Chen L.-M., Parker M.D., Boron W.F.;
RT   "Cloning and identification of novel human NBCn1 splice variants.";
RL   Submitted (JUL-2008) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 13 AND 14).
RC   TISSUE=Brain;
RA   Liu Y., Chen L., Parker M.D., Boron W.F.;
RT   "Cloning and identification of two novel human NBCn1 splice
RT   variants.";
RL   Submitted (DEC-2009) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Cervix;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   FUNCTION, INTERACTION WITH CFTR AND SLC9A3R1, AND DOMAIN.
RX   PubMed=12403779; DOI=10.1074/jbc.M201862200;
RA   Park M., Ko S.B.H., Choi J.Y., Muallem G., Thomas P.J., Pushkin A.,
RA   Lee M.-S., Kim J.Y., Lee M.G., Muallem S., Kurtz I.;
RT   "The cystic fibrosis transmembrane conductance regulator interacts
RT   with and regulates the activity of the HCO3- salvage transporter human
RT   Na+-HCO3-cotransport isoform 3.";
RL   J. Biol. Chem. 277:50503-50509(2002).
RN   [10]
RP   INTERACTION WITH ATP6V1B1 AND SLC9A3R1, AND MUTAGENESIS OF LEU-1214.
RX   PubMed=12444018; DOI=10.1152/ajpcell.00225.2002;
RA   Pushkin A., Abuladze N., Newman D., Muronets V., Sassani P.,
RA   Tatishchev S., Kurtz I.;
RT   "The COOH termini of NBC3 and the 56-kDa H+-ATPase subunit are PDZ
RT   motifs involved in their interaction.";
RL   Am. J. Physiol. 284:C667-C673(2003).
RN   [11]
RP   INTERACTION WITH CA2, REGULATION, AND MUTAGENESIS OF 1135-ASP-ASP-1136
RP   AND 1163-ASP--ASP-1165.
RX   PubMed=14736710; DOI=10.1152/ajpcell.00382.2003;
RA   Loiselle F.B., Morgan P.E., Alvarez B.V., Casey J.R.;
RT   "Regulation of the human NBC3 Na+/HCO3- cotransporter by carbonic
RT   anhydrase II and PKA.";
RL   Am. J. Physiol. 286:C1423-C1433(2004).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites
RT   from human T cells using immobilized metal affinity chromatography and
RT   tandem mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [13]
RP   INTERACTION WITH USH1C.
RX   PubMed=16301216; DOI=10.1093/hmg/ddi417;
RA   Reiners J., van Wijk E., Maerker T., Zimmermann U., Juergens K.,
RA   te Brinke H., Overlack N., Roepman R., Knipper M., Kremer H.,
RA   Wolfrum U.;
RT   "Scaffold protein harmonin (USH1C) provides molecular links between
RT   Usher syndrome type 1 and type 2.";
RL   Hum. Mol. Genet. 14:3933-3943(2005).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1167 AND SER-1176, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-403 AND SER-1213,
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263 (ISOFORMS 11; 6 AND
RP   9), PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1109 AND SER-1115
RP   (ISOFORM 13), PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-267
RP   (ISOFORMS 13 AND 14), PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT
RP   SER-258 (ISOFORM 2), PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT
RP   SER-1010 AND SER-1016 (ISOFORM 3), PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-168 (ISOFORMS 3 AND 4), PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-774 AND SER-780 (ISOFORM 5), PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-1105 AND SER-1111 (ISOFORM 6), PHOSPHORYLATION
RP   [LARGE SCALE ANALYSIS] AT SER-1233 AND SER-1239 (ISOFORM 7),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1220 AND SER-1226
RP   (ISOFORM 8), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [17]
RP   REVIEW, AND ALTERNATIVE SPLICING.
RX   PubMed=19448079; DOI=10.1242/jeb.028563;
RA   Boron W.F., Chen L., Parker M.D.;
RT   "Modular structure of sodium-coupled bicarbonate transporters.";
RL   J. Exp. Biol. 212:1697-1706(2009).
RN   [18]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-776; ASN-786 AND ASN-791.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1167 AND SER-1176,
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263 (ISOFORMS 11; 6 AND
RP   9), PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1077 (ISOFORM 13),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-267 (ISOFORMS 13 AND
RP   14), PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-258 (ISOFORM 2),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-168 (ISOFORMS 3 AND 4),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-742 (ISOFORM 5),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1073 (ISOFORM 6),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1201 (ISOFORM 7),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1188 (ISOFORM 8), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1176, PHOSPHORYLATION
RP   [LARGE SCALE ANALYSIS] AT SER-260 AND SER-263 (ISOFORMS 11; 6 AND 9),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1106 AND SER-1109
RP   (ISOFORM 13), PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-264 AND
RP   SER-267 (ISOFORMS 13 AND 14), PHOSPHORYLATION [LARGE SCALE ANALYSIS]
RP   AT SER-255 AND SER-258 (ISOFORM 2), PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-1007 AND SER-1010 (ISOFORM 3), PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-165 AND SER-168 (ISOFORMS 3 AND 4),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-771 AND SER-774 (ISOFORM
RP   5), PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1102 AND SER-1105
RP   (ISOFORM 6), PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1230 AND
RP   SER-1233 (ISOFORM 7), PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT
RP   SER-1217 AND SER-1220 (ISOFORM 8), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-242 AND SER-403,
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263 (ISOFORMS 11; 6 AND
RP   9), PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1106 (ISOFORM 13),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-267 (ISOFORMS 13 AND
RP   14), PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-258 (ISOFORM 2),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1007 (ISOFORM 3),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-168 (ISOFORMS 3 AND 4),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-771 (ISOFORM 5),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1102 (ISOFORM 6),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1230 (ISOFORM 7),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1217 (ISOFORM 8), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-55; SER-242; SER-403;
RP   SER-407; SER-556 AND THR-557, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Electroneutral sodium- and bicarbonate-dependent
CC       cotransporter with a Na(+):HCO3(-) 1:1 stoichiometry. Regulates
CC       intracellular pH and may play a role in bicarbonate salvage in
CC       secretory epithelia. May also have an associated sodium channel
CC       activity. {ECO:0000269|PubMed:10347222,
CC       ECO:0000269|PubMed:12403779}.
CC   -!- ENZYME REGULATION: Transporter activity is regulated by
CC       CA2/carbonic anhydrase 2, cAMP and PKA. Insensitive to stilbene
CC       derivatives. PubMed:10347222 states it is inhibited by 5-(N-ethyl-
CC       N-isopropyl)-amiloride (EIPA).
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=24 mM for external sodium {ECO:0000269|PubMed:10347222};
CC   -!- SUBUNIT: Interacts with CFTR through SLC9A3R1/EBP50. Interacts
CC       with USH1C. Forms a complex with ATP6V1B1 and SLC9A3R1/EBP50.
CC       Interacts in a pH dependent-manner with CA2/carbonic anhydrase 2.
CC       {ECO:0000269|PubMed:12403779, ECO:0000269|PubMed:12444018,
CC       ECO:0000269|PubMed:14736710, ECO:0000269|PubMed:16301216}.
CC   -!- SUBCELLULAR LOCATION: Basolateral cell membrane; Multi-pass
CC       membrane protein. Apical cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}. Cell projection, stereocilium
CC       {ECO:0000250}. Note=Also described at the apical cell membrane.
CC       Localizes to the stereocilia of cochlear outer hair cells and to
CC       the lateral membrane of cochlear inner hair cells (By similarity).
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=14;
CC       Name=1; Synonyms=mNBC3, NBCn1-A;
CC         IsoId=Q9Y6M7-1; Sequence=Displayed;
CC       Name=2; Synonyms=NBCn1-F;
CC         IsoId=Q9Y6M7-2; Sequence=VSP_047844;
CC         Note=Contains a phosphoserine at position 258. Contains a
CC         phosphoserine at position 255. {ECO:0000244|PubMed:18669648,
CC         ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
CC         ECO:0000244|PubMed:21406692};
CC       Name=3;
CC         IsoId=Q9Y6M7-3; Sequence=VSP_047839, VSP_047842, VSP_047844,
CC                                  VSP_047849;
CC         Note=Contains a phosphoserine at position 168. Contains a
CC         phosphoserine at position 1010. Contains a phosphoserine at
CC         position 1016. Contains a phosphoserine at position 165.
CC         Contains a phosphoserine at position 1007.
CC         {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
CC         ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692};
CC       Name=4;
CC         IsoId=Q9Y6M7-4; Sequence=VSP_047839, VSP_047842, VSP_047844;
CC         Note=Contains a phosphoserine at position 168. Contains a
CC         phosphoserine at position 165. {ECO:0000244|PubMed:18669648,
CC         ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
CC         ECO:0000244|PubMed:21406692};
CC       Name=5;
CC         IsoId=Q9Y6M7-5; Sequence=VSP_047838, VSP_047845, VSP_047848;
CC         Note=No experimental confirmation available. Contains a
CC         phosphoserine at position 774. Contains a phosphoserine at
CC         position 780. Contains a phosphoserine at position 742. Contains
CC         a phosphoserine at position 771. {ECO:0000244|PubMed:18669648,
CC         ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
CC         ECO:0000244|PubMed:21406692};
CC       Name=6; Synonyms=NBCn1-G;
CC         IsoId=Q9Y6M7-6; Sequence=VSP_047840, VSP_047844, VSP_047848;
CC         Note=Contains a phosphoserine at position 263. Contains a
CC         phosphoserine at position 1105. Contains a phosphoserine at
CC         position 1111. Contains a phosphoserine at position 1073.
CC         Contains a phosphoserine at position 260. Contains a
CC         phosphoserine at position 1102. {ECO:0000244|PubMed:18669648,
CC         ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
CC         ECO:0000244|PubMed:21406692};
CC       Name=7; Synonyms=NBCn1-D;
CC         IsoId=Q9Y6M7-7; Sequence=VSP_047841, VSP_047848;
CC         Note=Contains a phosphoserine at position 1233. Contains a
CC         phosphoserine at position 1239. Contains a phosphoserine at
CC         position 1201. Contains a phosphoserine at position 1230.
CC         {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
CC         ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692};
CC       Name=8; Synonyms=NBCn1-C;
CC         IsoId=Q9Y6M7-8; Sequence=VSP_047841, VSP_047843, VSP_047848;
CC         Note=Contains a phosphoserine at position 1220. Contains a
CC         phosphoserine at position 1226. Contains a phosphoserine at
CC         position 1188. Contains a phosphoserine at position 1217.
CC         {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
CC         ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692};
CC       Name=9; Synonyms=NBCn1-E;
CC         IsoId=Q9Y6M7-9; Sequence=VSP_047840, VSP_047844;
CC         Note=Contains a phosphoserine at position 263. Contains a
CC         phosphoserine at position 260. {ECO:0000244|PubMed:18669648,
CC         ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
CC         ECO:0000244|PubMed:21406692};
CC       Name=10;
CC         IsoId=Q9Y6M7-10; Sequence=VSP_047840, VSP_047843, VSP_047846,
CC                                   VSP_047847;
CC       Name=11;
CC         IsoId=Q9Y6M7-11; Sequence=VSP_047840, VSP_047844, VSP_047846,
CC                                   VSP_047847;
CC         Note=Contains a phosphoserine at position 263. Contains a
CC         phosphoserine at position 260. {ECO:0000244|PubMed:18669648,
CC         ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
CC         ECO:0000244|PubMed:21406692};
CC       Name=12; Synonyms=NBCn1-H;
CC         IsoId=Q9Y6M7-12; Sequence=VSP_047840, VSP_047843;
CC       Name=13;
CC         IsoId=Q9Y6M7-13; Sequence=VSP_047841, VSP_047844, VSP_047848;
CC         Note=Contains a phosphoserine at position 267. Contains a
CC         phosphoserine at position 1109. Contains a phosphoserine at
CC         position 1115. Contains a phosphoserine at position 1077.
CC         Contains a phosphoserine at position 264. Contains a
CC         phosphoserine at position 1106. {ECO:0000244|PubMed:18669648,
CC         ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
CC         ECO:0000244|PubMed:21406692};
CC       Name=14;
CC         IsoId=Q9Y6M7-14; Sequence=VSP_047841, VSP_047844, VSP_047846,
CC                                   VSP_047847;
CC         Note=Contains a phosphoserine at position 267. Contains a
CC         phosphoserine at position 264. {ECO:0000244|PubMed:18669648,
CC         ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
CC         ECO:0000244|PubMed:21406692};
CC   -!- TISSUE SPECIFICITY: Highly expressed in testis and spleen. Also
CC       expressed in retina, colon, small intestine, ovary, thymus,
CC       prostate, muscle, heart and kidney. Isoform 1 is expressed in
CC       skeletal muscle and heart muscle. {ECO:0000269|PubMed:9610397}.
CC   -!- DOMAIN: The PDZ-binding motif mediates interaction with the CFTR,
CC       SLC9A3R1/EBP50 complex and probably with USH1C.
CC       {ECO:0000269|PubMed:12403779}.
CC   -!- SIMILARITY: Belongs to the anion exchanger (TC 2.A.31) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB012130; BAA25898.1; -; mRNA.
DR   EMBL; AF047033; AAD38322.1; -; mRNA.
DR   EMBL; AF089726; AAG16773.1; -; mRNA.
DR   EMBL; AF053755; AAF21720.1; -; mRNA.
DR   EMBL; EU499349; ACB47400.1; -; mRNA.
DR   EMBL; EU934246; ACH61958.1; -; mRNA.
DR   EMBL; EU934248; ACH61960.1; -; mRNA.
DR   EMBL; EU934249; ACH61961.1; -; mRNA.
DR   EMBL; EU934250; ACH61962.1; -; mRNA.
DR   EMBL; FJ178574; ACI24740.1; -; mRNA.
DR   EMBL; FJ178575; ACI24741.1; -; mRNA.
DR   EMBL; FJ178576; ACI24742.1; -; mRNA.
DR   EMBL; GU354307; ADC32649.1; -; mRNA.
DR   EMBL; GU354308; ADC32650.1; -; mRNA.
DR   EMBL; GU354309; ADC32651.1; -; mRNA.
DR   EMBL; GU354310; ADC32652.1; -; mRNA.
DR   EMBL; CR627428; CAH10515.1; -; mRNA.
DR   EMBL; AC099535; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471055; EAW64382.1; -; Genomic_DNA.
DR   CCDS; CCDS33721.1; -. [Q9Y6M7-1]
DR   CCDS; CCDS58819.1; -. [Q9Y6M7-2]
DR   CCDS; CCDS58820.1; -. [Q9Y6M7-6]
DR   CCDS; CCDS82747.1; -. [Q9Y6M7-7]
DR   CCDS; CCDS82749.1; -. [Q9Y6M7-8]
DR   CCDS; CCDS82750.1; -. [Q9Y6M7-9]
DR   CCDS; CCDS82751.1; -. [Q9Y6M7-12]
DR   PIR; JE0160; JE0160.
DR   RefSeq; NP_001245308.1; NM_001258379.1. [Q9Y6M7-6]
DR   RefSeq; NP_001245309.1; NM_001258380.1. [Q9Y6M7-2]
DR   RefSeq; NP_001308032.1; NM_001321103.1. [Q9Y6M7-7]
DR   RefSeq; NP_001308033.1; NM_001321104.1. [Q9Y6M7-8]
DR   RefSeq; NP_001308034.1; NM_001321105.1.
DR   RefSeq; NP_001308035.1; NM_001321106.1. [Q9Y6M7-12]
DR   RefSeq; NP_001308036.1; NM_001321107.1. [Q9Y6M7-9]
DR   RefSeq; NP_001308037.1; NM_001321108.1. [Q9Y6M7-13]
DR   RefSeq; NP_003606.3; NM_003615.4. [Q9Y6M7-1]
DR   RefSeq; XP_016863017.1; XM_017007528.1. [Q9Y6M7-5]
DR   RefSeq; XP_016863018.1; XM_017007529.1. [Q9Y6M7-5]
DR   UniGene; Hs.250072; -.
DR   ProteinModelPortal; Q9Y6M7; -.
DR   BioGrid; 114876; 28.
DR   IntAct; Q9Y6M7; 8.
DR   MINT; MINT-1632023; -.
DR   STRING; 9606.ENSP00000295736; -.
DR   DrugBank; DB01390; Sodium bicarbonate.
DR   TCDB; 2.A.31.2.11; the anion exchanger (ae) family.
DR   iPTMnet; Q9Y6M7; -.
DR   PhosphoSitePlus; Q9Y6M7; -.
DR   BioMuta; SLC4A7; -.
DR   DMDM; 229462789; -.
DR   EPD; Q9Y6M7; -.
DR   PaxDb; Q9Y6M7; -.
DR   PeptideAtlas; Q9Y6M7; -.
DR   PRIDE; Q9Y6M7; -.
DR   DNASU; 9497; -.
DR   Ensembl; ENST00000295736; ENSP00000295736; ENSG00000033867. [Q9Y6M7-1]
DR   Ensembl; ENST00000428386; ENSP00000416368; ENSG00000033867. [Q9Y6M7-2]
DR   Ensembl; ENST00000437179; ENSP00000394252; ENSG00000033867. [Q9Y6M7-9]
DR   Ensembl; ENST00000437266; ENSP00000409418; ENSG00000033867. [Q9Y6M7-11]
DR   Ensembl; ENST00000438530; ENSP00000407304; ENSG00000033867. [Q9Y6M7-10]
DR   Ensembl; ENST00000440156; ENSP00000414797; ENSG00000033867. [Q9Y6M7-8]
DR   Ensembl; ENST00000446700; ENSP00000406605; ENSG00000033867. [Q9Y6M7-12]
DR   Ensembl; ENST00000454389; ENSP00000390394; ENSG00000033867. [Q9Y6M7-7]
DR   Ensembl; ENST00000455077; ENSP00000407382; ENSG00000033867. [Q9Y6M7-6]
DR   Ensembl; ENST00000457377; ENSP00000408323; ENSG00000033867. [Q9Y6M7-11]
DR   GeneID; 9497; -.
DR   KEGG; hsa:9497; -.
DR   UCSC; uc003cdu.6; human. [Q9Y6M7-1]
DR   CTD; 9497; -.
DR   DisGeNET; 9497; -.
DR   GeneCards; SLC4A7; -.
DR   HGNC; HGNC:11033; SLC4A7.
DR   HPA; CAB022494; -.
DR   HPA; HPA035857; -.
DR   MIM; 603353; gene.
DR   neXtProt; NX_Q9Y6M7; -.
DR   OpenTargets; ENSG00000033867; -.
DR   PharmGKB; PA35899; -.
DR   eggNOG; KOG1172; Eukaryota.
DR   eggNOG; ENOG410XPHD; LUCA.
DR   GeneTree; ENSGT00760000119021; -.
DR   HOGENOM; HOG000280684; -.
DR   HOVERGEN; HBG004326; -.
DR   InParanoid; Q9Y6M7; -.
DR   KO; K13858; -.
DR   OMA; ETYAFNM; -.
DR   OrthoDB; EOG091G01FT; -.
DR   PhylomeDB; Q9Y6M7; -.
DR   TreeFam; TF313630; -.
DR   Reactome; R-HSA-425381; Bicarbonate transporters.
DR   ChiTaRS; SLC4A7; human.
DR   GeneWiki; SLC4A7; -.
DR   GenomeRNAi; 9497; -.
DR   PRO; PR:Q9Y6M7; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000033867; -.
DR   CleanEx; HS_SLC4A7; -.
DR   ExpressionAtlas; Q9Y6M7; baseline and differential.
DR   Genevisible; Q9Y6M7; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0032420; C:stereocilium; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; IEA:Ensembl.
DR   GO; GO:0008509; F:anion transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0005452; F:inorganic anion exchanger activity; IEA:InterPro.
DR   GO; GO:0008510; F:sodium:bicarbonate symporter activity; TAS:Reactome.
DR   GO; GO:0098656; P:anion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0060117; P:auditory receptor cell development; IBA:GO_Central.
DR   GO; GO:0015701; P:bicarbonate transport; IBA:GO_Central.
DR   GO; GO:0051453; P:regulation of intracellular pH; IBA:GO_Central.
DR   Gene3D; 3.40.930.10; -; 1.
DR   InterPro; IPR013769; Band3_cytoplasmic_dom.
DR   InterPro; IPR011531; HCO3_transpt_C.
DR   InterPro; IPR003020; HCO3_transpt_euk.
DR   InterPro; IPR016152; PTrfase/Anion_transptr.
DR   PANTHER; PTHR11453; PTHR11453; 1.
DR   Pfam; PF07565; Band_3_cyto; 1.
DR   Pfam; PF00955; HCO3_cotransp; 1.
DR   PRINTS; PR01231; HCO3TRNSPORT.
DR   SUPFAM; SSF55804; SSF55804; 2.
DR   TIGRFAMs; TIGR00834; ae; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Cell projection;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion transport;
KW   Membrane; Phosphoprotein; Polymorphism; Reference proteome; Sodium;
KW   Sodium transport; Symport; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1   1214       Sodium bicarbonate cotransporter 3.
FT                                /FTId=PRO_0000079233.
FT   TOPO_DOM      1    608       Extracellular. {ECO:0000255}.
FT   TRANSMEM    609    629       Helical. {ECO:0000255}.
FT   TOPO_DOM    630    637       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    638    658       Helical. {ECO:0000255}.
FT   TOPO_DOM    659    695       Extracellular. {ECO:0000255}.
FT   TRANSMEM    696    716       Helical. {ECO:0000255}.
FT   TOPO_DOM    717    725       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    726    746       Helical. {ECO:0000255}.
FT   TOPO_DOM    747    817       Extracellular. {ECO:0000255}.
FT   TRANSMEM    818    838       Helical. {ECO:0000255}.
FT   TOPO_DOM    839    861       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    862    882       Helical. {ECO:0000255}.
FT   TOPO_DOM    883    908       Extracellular. {ECO:0000255}.
FT   TRANSMEM    909    929       Helical. {ECO:0000255}.
FT   TOPO_DOM    930    954       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    955    975       Helical. {ECO:0000255}.
FT   TOPO_DOM    976   1011       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1012   1032       Helical. {ECO:0000255}.
FT   TOPO_DOM   1033   1034       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1035   1055       Helical. {ECO:0000255}.
FT   TOPO_DOM   1056   1092       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1093   1113       Helical. {ECO:0000255}.
FT   TOPO_DOM   1114   1214       Cytoplasmic. {ECO:0000255}.
FT   REGION     1134   1136       CA2-binding.
FT   MOTIF      1211   1214       PDZ-binding.
FT   MOD_RES      52     52       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BTY2}.
FT   MOD_RES      55     55       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      84     84       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9R1N3}.
FT   MOD_RES     150    150       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9R1N3}.
FT   MOD_RES     233    233       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BTY2}.
FT   MOD_RES     242    242       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     382    382       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BTY2}.
FT   MOD_RES     400    400       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9R1N3}.
FT   MOD_RES     403    403       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     407    407       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     556    556       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     557    557       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1167   1167       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES    1176   1176       Phosphoserine.
FT                                {ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES    1213   1213       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   CARBOHYD    171    171       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    269    269       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    398    398       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    406    406       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    776    776       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    786    786       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    791    791       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   DISULFID    766    768       {ECO:0000250|UniProtKB:Q9Y6R1}.
FT   DISULFID    802    814       {ECO:0000250|UniProtKB:Q9Y6R1}.
FT   VAR_SEQ       1    450       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_047838.
FT   VAR_SEQ       1     90       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:9610397,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_047839.
FT   VAR_SEQ       1     11       MERFRLEKKLP -> MEADGAGEQMRPLLTR (in
FT                                isoform 6, isoform 9, isoform 10, isoform
FT                                11 and isoform 12). {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_047840.
FT   VAR_SEQ       1     11       MERFRLEKKLP -> MEADGAGEQMRPLLTRVTSR (in
FT                                isoform 7, isoform 8, isoform 13 and
FT                                isoform 14). {ECO:0000303|Ref.4,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_047841.
FT   VAR_SEQ      91    118       SQRVQFILGTEDDDEEHIPHDLFTEMDE -> MAVTQFIHF
FT                                REEIMGNMFFIIIFSTKDK (in isoform 3 and
FT                                isoform 4). {ECO:0000303|PubMed:9610397,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_047842.
FT   VAR_SEQ     238    250       Missing (in isoform 8, isoform 10 and
FT                                isoform 12). {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_047843.
FT   VAR_SEQ     251    374       Missing (in isoform 2, isoform 3, isoform
FT                                4, isoform 6, isoform 9, isoform 11,
FT                                isoform 13 and isoform 14).
FT                                {ECO:0000303|PubMed:10347222,
FT                                ECO:0000303|PubMed:9610397,
FT                                ECO:0000303|Ref.3, ECO:0000303|Ref.4,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_047844.
FT   VAR_SEQ     451    465       PAVLLTGLTEVPVPT -> MEVVEAEKIVLLTSA (in
FT                                isoform 5).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_047845.
FT   VAR_SEQ     581    582       LF -> VQ (in isoform 10, isoform 11 and
FT                                isoform 14). {ECO:0000303|Ref.4,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_047846.
FT   VAR_SEQ     583   1214       Missing (in isoform 10, isoform 11 and
FT                                isoform 14). {ECO:0000303|Ref.4,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_047847.
FT   VAR_SEQ    1188   1188       S -> SVDPSIVNISDEMAKTAQWKALSMNTENAKVTRSNM
FT                                S (in isoform 5, isoform 6, isoform 7,
FT                                isoform 8 and isoform 13).
FT                                {ECO:0000303|PubMed:17974005,
FT                                ECO:0000303|Ref.4, ECO:0000303|Ref.5}.
FT                                /FTId=VSP_047848.
FT   VAR_SEQ    1189   1214       PDKPVSVKISFEDEPRKKYVDAETSL -> GDPSIGNISDE
FT                                MAKTAQWKALSMNTENAKVTRSNMSPDKPVSVK (in
FT                                isoform 3). {ECO:0000303|PubMed:9610397}.
FT                                /FTId=VSP_047849.
FT   VARIANT     326    326       E -> K (in dbSNP:rs3755652).
FT                                {ECO:0000269|PubMed:10347222,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_055317.
FT   MUTAGEN    1135   1136       DD->NN: Loss of interaction with CA2.
FT                                Loss of regulation by CA2.
FT                                {ECO:0000269|PubMed:14736710}.
FT   MUTAGEN    1163   1165       DDD->NNN: No effect on interaction with
FT                                CA2. No effect on regulation by CA2.
FT                                {ECO:0000269|PubMed:14736710}.
FT   MUTAGEN    1214   1214       L->G: Loss of interaction with ATP6V1B1.
FT                                {ECO:0000269|PubMed:12444018}.
SQ   SEQUENCE   1214 AA;  136044 MW;  7B4ADA1E3F26813C CRC64;
     MERFRLEKKL PGPDEEAVVD LGKTSSTVNT KFEKEELESH RAVYIGVHVP FSKESRRRHR
     HRGHKHHHRR RKDKESDKED GRESPSYDTP SQRVQFILGT EDDDEEHIPH DLFTEMDELC
     YRDGEEYEWK ETARWLKFEE DVEDGGDRWS KPYVATLSLH SLFELRSCIL NGTVMLDMRA
     STLDEIADMV LDNMIASGQL DESIRENVRE ALLKRHHHQN EKRFTSRIPL VRSFADIGKK
     HSDPHLLERN GEGLSASRHS LRTGLSASNL SLRGESPLSL LLGHLLPSSR AGTPAGSRCT
     TPVPTPQNSP PSSPSISRLT SRSSQESQRQ APELLVSPAS DDIPTVVIHP PEEDLEAALK
     GEEQKNEENV DLTPGILASP QSAPGNLDNS KSGEIKGNGS GGSRENSTVD FSKVDMNFMR
     KIPTGAEASN VLVGEVDFLE RPIIAFVRLA PAVLLTGLTE VPVPTRFLFL LLGPAGKAPQ
     YHEIGRSIAT LMTDEIFHDV AYKAKDRNDL LSGIDEFLDQ VTVLPPGEWD PSIRIEPPKS
     VPSQEKRKIP VFHNGSTPTL GETPKEAAHH AGPELQRTGR LFGGLILDIK RKAPFFLSDF
     KDALSLQCLA SILFLYCACM SPVITFGGLL GEATEGRISA IESLFGASLT GIAYSLFAGQ
     PLTILGSTGP VLVFEKILYK FCRDYQLSYL SLRTSIGLWT SFLCIVLVAT DASSLVCYIT
     RFTEEAFAAL ICIIFIYEAL EKLFDLGETY AFNMHNNLDK LTSYSCVCTE PPNPSNETLA
     QWKKDNITAH NISWRNLTVS ECKKLRGVFL GSACGHHGPY IPDVLFWCVI LFFTTFFLSS
     FLKQFKTKRY FPTKVRSTIS DFAVFLTIVI MVTIDYLVGV PSPKLHVPEK FEPTHPERGW
     IISPLGDNPW WTLLIAAIPA LLCTILIFMD QQITAVIINR KEHKLKKGAG YHLDLLMVGV
     MLGVCSVMGL PWFVAATVLS ISHVNSLKVE SECSAPGEQP KFLGIREQRV TGLMIFILMG
     LSVFMTSVLK FIPMPVLYGV FLYMGVSSLK GIQLFDRIKL FGMPAKHQPD LIYLRYVPLW
     KVHIFTVIQL TCLVLLWVIK VSAAAVVFPM MVLALVFVRK LMDLCFTKRE LSWLDDLMPE
     SKKKKEDDKK KKEKEEAERM LQDDDDTVHL PFEGGSLLQI PVKALKYSPD KPVSVKISFE
     DEPRKKYVDA ETSL
//
